Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

头孢吡肟 医学 内科学 优势比 单变量分析 人口 抗生素 多元分析 胃肠病学 生物 微生物学 抗生素耐药性 环境卫生 亚胺培南
作者
Nathaniel J. Rhodes,Joseph L. Kuti,David P. Nicolau,Scott Van Wart,Anthony M. Nicasio,Jiajun Liu,Benjamin J. Lee,Michael Neely,Marc H. Scheetz
出处
期刊:Antimicrobial Agents and Chemotherapy [American Society for Microbiology]
卷期号:60 (3): 1401-1410 被引量:53
标识
DOI:10.1128/aac.01956-15
摘要

The percentage of time that free drug concentrations remain above the MIC (fT>MIC) that is necessary to prevent mortality among cefepime-treated patients with Gram-negative bloodstream infections (GNBSI) is poorly defined. We conducted a retrospective study of adult patients with GNBSI. Eligible cases were frequency matched to ensure categorical representation from all MICs. Organism, MIC, infection source, gender, age, serum creatinine, weight, antibiotic history, and modified APACHE II score were collected from hospital records. Two population pharmacokinetic models (models 1 and 2) were used to impute exposures over the first 24 h in each patient from mean model parameters, covariates, and dosing history. From the imputed exposures, survival thresholds for fT>MIC were identified using classification and regression tree (CART) analysis and analyzed as nominal variables for univariate and multivariate regressions. A total of 180 patients were included in the analysis, of whom 13.9% died and 86.1% survived. Many patients (46.7% [n = 84/180]) received combination therapy with cefepime. Survivors had higher mean (standard deviation [SD]) fT>MIC than those who died (model 1, 74.2% [29.6%] versus 52.1% [33.8%], P < 0.001; model 2, 85.9% [24.0%] versus 64.4% [31.4%], P < 0.001). CART identified fT>MIC threshold values for greater survival according to models 1 and 2 at >68% and >74%, respectively. Survival was improved for those with fT>MIC of >68% (model 1 adjusted odds ratio [aOR], 7.12; 95% confidence interval [CI], 1.90 to 26.7; P = 0.004) and >74% (model 2 aOR, 6.48; 95% CI, 1.90 to 22.1) after controlling for clinical covariates. Similarly, each 1% increase in cefepime fT>MIC resulted in a 2% improvement in multivariate survival probability (P = 0.015). Achieving a cefepime fT>MIC of 68 to 74% was associated with a higher odds of survival for patients with GNBSI. Regimens targeting this exposure should be aggressively pursued.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhaoxiaonuan完成签到,获得积分10
1秒前
Jara完成签到 ,获得积分10
1秒前
1秒前
1秒前
贪玩鸵鸟完成签到,获得积分10
2秒前
gexiaoyang发布了新的文献求助10
2秒前
沉静的冥幽完成签到,获得积分10
5秒前
lifecxqdh完成签到,获得积分10
5秒前
明理易巧发布了新的文献求助10
7秒前
7秒前
8秒前
11秒前
量子星尘发布了新的文献求助10
11秒前
12秒前
一十六完成签到,获得积分10
12秒前
15秒前
17秒前
abtx314发布了新的文献求助10
17秒前
木木木完成签到,获得积分10
17秒前
隐形曼青应助pomelo采纳,获得10
20秒前
Young发布了新的文献求助10
20秒前
20秒前
幸福大白发布了新的文献求助10
20秒前
Lee发布了新的文献求助10
22秒前
魂殇完成签到,获得积分10
23秒前
24秒前
宇老师完成签到,获得积分10
25秒前
幸福大白发布了新的文献求助10
25秒前
阮大帅气完成签到,获得积分10
27秒前
张张张发布了新的文献求助10
27秒前
29秒前
量子星尘发布了新的文献求助10
30秒前
Young完成签到,获得积分10
31秒前
hubo完成签到,获得积分10
31秒前
31秒前
肥仔发布了新的文献求助10
32秒前
Zhong发布了新的文献求助10
33秒前
研友_nPb9e8完成签到,获得积分10
34秒前
马上毕业完成签到 ,获得积分10
35秒前
36秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Organic Chemistry 3000
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
Should We Stop Endovascular Treatment of M2 Occlusions?: A Critical Look at Recent Evidence 450
International socialism & Australian labour : the Left in Australia, 1919-1939 400
Bulletin de la Societe Chimique de France 400
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4282077
求助须知:如何正确求助?哪些是违规求助? 3810238
关于积分的说明 11935469
捐赠科研通 3456846
什么是DOI,文献DOI怎么找? 1895743
邀请新用户注册赠送积分活动 944822
科研通“疑难数据库(出版商)”最低求助积分说明 848561